Insider Transactions in Q4 2023 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2023
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,516
+2.51%
|
$27,032
$2.61 P/Share
|
Dec 20
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Indirect |
636
-3.41%
|
-
|